A very preterm male infant faced a dangerous drop in platelets. His mother had immune thrombocytopenia, a condition where the immune system attacks platelets. This baby also had intraventricular hemorrhage, bleeding inside the brain. Doctors needed to act fast to stop the bleeding and help his blood clot properly.
The team gave him intravenous immunoglobulin, a treatment that helps calm the immune system. They also gave him multiple platelet transfusions to replace the cells he lost. By day 14, his platelet count began to rise. By day 19, the number was normal again.
No safety problems were reported during this short time. However, this is a case report, meaning it follows only one patient. Evidence in very preterm infants remains limited. This story highlights the need for active and comprehensive management strategies. Doctors must provide individualized interventions for immune thrombocytopenia while addressing general problems associated with prematurity.
The presentation suggests a multifactorial pathogenesis in very preterm neonatal immune thrombocytopenia. This means the cause involves maternal antibody mediated platelet destruction, gestational age related limits in platelet production, and potential genetics mediated immune dysregulation. This single case shows how complex the situation can be.